• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

FSD Pharma Inc. - Class B Subordinate Voting Shares (NQ:HUGE)

0.0899 UNCHANGED
Last Price Updated: 4:00 PM EDT, Aug 14, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about FSD Pharma Inc. - Class B Subordinate Voting Shares

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
News headline image
Quantum Biopharma Announces Intention to Complete Debt Settlements and Provides Corporate Update
August 23, 2024
Via ACCESSWIRE
News headline image
HUGE Stock Earnings: FSD Pharma Misses EPS for Q2 2024 ↗
August 14, 2024
HUGE stock results show that FSD Pharma missed analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗
August 13, 2024
It's time to dive into the biggest pre-market stock movers for Tuesday as we check out all of the hottest news moving shares this morning. 
Via InvestorPlace
News headline image
Why Rumble Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket ↗
August 13, 2024
 
Via Benzinga
News headline image
Why FSD Pharma Stock Is Seeing Huge Gains ↗
August 09, 2024
FSD Pharma shares are trading higher Friday after the company provided an update on its investment in Celly Nutrition. Here's a look at what's going on: 
Via Benzinga
News headline image
FSD Pharma Rebrands As Quantum BioPharma: Major Share Consolidation Announced ↗
August 12, 2024
FSD Pharma announces share consolidation, rebranding as Quantum BioPharma Ltd., and a new private placement to strengthen market position and meet Nasdaq requirements. 
Via Benzinga
InvestorNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Shareholders Approve Plans for Share Consolidation, Name Change
August 12, 2024
Via Investor Brand Network
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗
August 12, 2024
It's time to dive into the biggest pre-market stock movers for Monday morning with all of the latest news affecting shares today! 
Via InvestorPlace
News headline image
Why Ainos Shares Are Trading Higher By Around 38%; Here Are 20 Stocks Moving Premarket ↗
August 12, 2024
 
Via Benzinga
InvestorNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Reports on Status of New Product, Investment in Celly Nutrition Corp.
August 09, 2024
Via Investor Brand Network
News headline image
US Stocks Edge Lower; EchoStar Shares Tumble After Q2 Results ↗
August 09, 2024
 
Via Benzinga
News headline image
FSD Pharma Is Up 216% Today. What Is Going On With HUGE Stock? ↗
August 09, 2024
FSD Pharma stock is up on Friday as HUGe ivnestors react to an update on its investment in Celly Nutrition and a new product launch. 
Via InvestorPlace
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗
August 09, 2024
We have all of the biggest pre-market stock movers that traders need to know about on Friday with the latest news breakdowns! 
Via InvestorPlace
News headline image
Why Doximity Shares Are Trading Higher By Over 28%; Here Are 20 Stocks Moving Premarket ↗
August 09, 2024
 
Via Benzinga
News headline image
FSD Pharma Provides Update on its Investment in Celly Nutrition Corp. Who Secures Additional Financing to Launch unbuzzd(TM) Stick Packs this Month - Created by a World-Class Pharmaceutical Research & Development Team
August 09, 2024
Via ACCESSWIRE
News headline image
Why Carvana Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket ↗
August 01, 2024
 
Via Benzinga
InvestorNewsBreaks – FSD Pharma Inc.’s (NASDAQ: HUGE) (CSE: HUGE) (FRA:0K9A) Revolutionary Rapid Detoxification Drink Spotlighted in 24/7 Market News Report
July 25, 2024
Via Investor Brand Network
BioMedNewsBreaks — FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Holds Annual General and Special Meeting of Shareholders, Reports on Voting Results
July 24, 2024
Via Investor Brand Network
BioMedNewsBreaks — FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Amends Original Material Change Report, Files Amended and Restated MCR
July 05, 2024
Via Investor Brand Network
BioMedNewsBreaks — FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Retains Digital Marketing Platform to Increase Market Awareness
July 01, 2024
Via Investor Brand Network
News headline image
FSD Pharma provides Corporate Update
June 28, 2024
Via ACCESSWIRE
InvestorNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Awarded Final Judgment, Confirmation of $3M-Plus Arbitration Award
June 28, 2024
Via Investor Brand Network
News headline image
FSD Pharma, Inc. Wins Final Judgment to Confirm Arbitration Award of $3,059,998 Plus Interest Entered Against Dr. Raza Bokhari, Currently Serving as Chairman and CEO of Medicus Pharma Ltd.
June 28, 2024
Via ACCESSWIRE
BioMedNewsBreaks — FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Notes ‘Important Step’ as Phase 1 Lucid-21-302 Trial Receives HREC Approval
June 27, 2024
Via Investor Brand Network
InvestorNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Notes ‘Important Step’ as Phase 1 Lucid-21-302 Trial Receives HREC Approval
June 27, 2024
Via Investor Brand Network
News headline image
FSD Pharma Receives Ethics Committee Approval for a Phase-1 Multiple Ascending Doses Clinical Trial for Lucid-21-302 (Lucid-MS) in Australia
June 27, 2024
Via ACCESSWIRE
InvestorNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA:0K9A) Signs Option Agreement with USC to Exclusively Evaluate Novel Technology for Commercialization
June 13, 2024
Via Investor Brand Network
News headline image
FSD Pharma Enters Into an Exclusive Option Agreement With the University of Southern California To Evaluate Novel Dietary Supplement Technology for unbuzzd(TM) and Other Business Applications
June 13, 2024
Via ACCESSWIRE
InvestorNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Announces IRB Approval for Acute Alcohol Intoxication Study
June 04, 2024
Via Investor Brand Network
News headline image
FSD Pharma Receives Institutional Review Board Approval to Study the Safety and Efficacy of Unbuzzd(TM) in Acute Alcohol Intoxication
June 04, 2024
Via ACCESSWIRE
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap